Design and synthesis of novel GLP-1 analogs that have significantly improved in vivo activities

被引：0
|
作者：
Dong, Jesse Z. [1 ]
Shen, Yeelana [1 ]
Zhang, Jundong [1 ]
Taylor, John E. [1 ]
Woon, Chee-Wai [1 ]
Morgan, Barry [1 ]
Skinner, Steve [1 ]
Cawthorne, Michael [1 ]
Culler, Michael [1 ]
Moreau, Jacques-Pierre [1 ]
机构：
[1] Biomeasure Inc, IPSEN Grp, Milford, MA 01757 USA
来源：
PEPTIDE REVOLUTION: GENOMICS, PROTEOMICS & THERAPEUTICS | 2004年
关键词：
D O I：
暂无
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
引用
收藏
页码：625 / 627
页数：3
相关论文
共 50 条
  • [1] Design and synthesis of a novel GLP-1 analog, BIM-51077.: Which has significantly improved in vivo activity
    Dong, JZ
    Shen, Y
    Zhang, J
    Taylor, JE
    Woon, CW
    Morgan, B
    Skinner, S
    Cawthorne, M
    Culler, M
    Moreau, JP
    BIOPOLYMERS, 2003, 71 (03) : 297 - 297
  • [2] Biological activities of GLP-1 analogs in vitro and in vivo
    Xiao, Q
    Giguere, J
    Jeng, W
    Pierre, SS
    Brubaker, PL
    Wheeler, MB
    DIABETES, 2000, 49 : A227 - A227
  • [3] Novel long-acting GLP-1 analogs with superior in vivo bioavailability
    Sakamuri, Sukumar
    Huang, Jie
    Fu, Yanwen
    Oates, Bryan
    Hatcher, Ellen
    Betancourt, Oscar
    Del Rosario, Joselyn
    Callans, Sherri
    Murphy, Robert
    Lappe, Rodney
    Woodnutt, Gary
    Bradshaw, Curt
    Levin, Nancy
    DIABETES, 2007, 56 : A151 - A151
  • [4] Characterisation of radiolabelled GLP-1 analogs for in vivo targeting of insulinomas
    Brom, M.
    Boerman, O.
    Behe, M.
    Oyen, W.
    Gotthardt, M.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2008, 35 : S319 - S319
  • [5] Design and evaluation of novel thrombin-based GLP-1 analogs with peptidic albumin binding domain for the controlled release of GLP-1
    Niu, Xianli
    Nong, Shirong
    Zhang, Xiaomin
    Li, Xiangyang
    Wang, Cheng
    Li, Wei
    Zhou, Tianhong
    RSC ADVANCES, 2020, 10 (08) : 4725 - 4732
  • [6] GLP-1 analogs containing disulfide bond exhibited prolonged half-life in vivo than GLP-1
    Li, Ying
    Zheng, Xuemin
    Tang, Lida
    Xu, Weiren
    Gong, Min
    PEPTIDES, 2011, 32 (06) : 1303 - 1312
  • [7] Synthesis and activity of proteolysis-resistant GLP-1 analogs
    Smiley, DL
    Stucky, RD
    Chen, VJ
    Flora, DB
    Kriauciunas, A
    Hine, BM
    Hoffmann, JA
    Johnson, WT
    Owens, RA
    Yakubu-Madus, FE
    DiMarchi, RD
    PEPTIDES: FRONTIERS OF PEPTIDES SCIENCE, 1999, : 615 - 616
  • [8] GLP-1 ANALOGS FOR THE TREATMENT OF OBESITY
    Sever, M. Jensterle
    DIABETES TECHNOLOGY & THERAPEUTICS, 2023, 25 : A6 - A6
  • [9] GLP-1 Analogs Represent a Novel Treatment Strategy for Diabetic Encephalopathy
    Okouchi, Masahiro
    Okayama, Naotsuka
    Shigeki, Goji
    Iwama, Tadashi
    Katsuno, Tetsuya
    Asada, Kaoru
    Hattori, Kohei
    Goto, Akitomo
    Kamiya, Yasutaka
    Ohno, Tsuneo
    Joh, Takashi
    DIABETES, 2012, 61 : A145 - A145
  • [10] Synthesis of histidine analogs for SAR studies in relation to GLP-1 activation
    MacLeod, Brianna L.
    Boyd, Victoria
    Haines, David R.
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2011, 241
12345